Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis : experience from Japanese clinical trials

スポンサーリンク

概要

• 論文の詳細を見る
• 2011-12-01

著者

• IMAGAWA Tomoyuki

  Department of Pediatrics, Yokohama City University School of Medicine

• 根路銘 安仁

  Department Of Pediatrics Kagoshima University Graduate School Of Medical And Dental Sciences

• Kawano Yoshifumi

  Kagoshima University Hospital Department Of Pediatrics

• Takei Syuji

  Department Of Pediatrics Kagoshima University Graduate School Of Medical And Dental Sciences

• Mori Masaaki

  Department Of Pediatrics Yokohama City University School Of Medicine

• Yokota Shumpei

  Department Of Pediatrics Yokohama City University School Of Medicine

• Yokota Shumpei

  Yokohama City University

• TAKEI Syuji

  Kagoshima University School of Medicine

• IMANAKA Hiroyuki

  Kagoshima University School of Medicine

• Imanaka Hiroyuki

  Department Of Pediatrics Kagoshima University Graduate School Of Medical And Dental Sciences

• Yokota Shumpei

  Department Of Pediatrics Yokohama City University

• Kurosawa Rumiko

  Department Of Pediatrics Yokohama City University School Of Medicine

• Imagawa Tomoyuki

  Department Of Pediatrics Yokohama City University

• MORI Masaaki

  Yokohama City University School of Medicine

• IMAGAWA Tomoyuki

  Yokohama City University School of Medicine

• NEROME Yasuhito

  Kagoshima University School of Medicine

• KUROSAWA Rumiko

  Yokohama City University School of Medicine

• SUGIYAMA Noriko

  Pfizer Inc

• YUASA Hirotoshi

  Pfizer Inc

• FLETCHER Tracey

  Pfizer Inc, Collegeville

• WAJDULA Joseph

  Pfizer Inc, Collegeville

• Wajdula Joseph

  Pfizer Inc Collegeville

• Fletcher Tracey

  Pfizer Inc Collegeville

• Kawano Yoshifumi

  Kagoshima University School Of Medicine

• Takei Syuji

  Department Of Pediatrics Kagoshima University

• Imanaka Hiroyuki

  Department Of Pediatrics Faculty Of Medicine Kagoshima University

関連論文

• 日本における死亡退院した児の家族への精神的サポートの検討
• Soluble tumor necrosis factor receptor-I in preterm infants with chorioamnionitis
• 小児結核における全血インターフェロンγ応答測定法の有用性について
• Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
• Suppressed neutrophil function in children with acute lymphoblastic leukemia
• Comparison of markers for fetal inflammatory response syndrome : Fetal blood interleukin-6 and neonatal urinary β_2-microglobulin
• Cross-cultural adaptation and validation of the Japanese version of the Childhood Health Assessment Questionnaire (CHAQ)
• メチルプレドニゾロンパルス療法は小児ステロイド白内障発症の危険因子である
• A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate
• Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
• 若年性関節リウマチにおける結成ヒアルロン酸値の診断的意義の検討
• Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis
• Acute theumatic fever and poststreptococcal acute glomerulonephritis caused by T serotype 12 Streptococcus
• Methotrexate for the treatment of juvenile idiopathic arthritis : process to approval for JIA indication in Japan
• Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007)
• Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone
• Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient
• Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease
• Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin
• Descending necrotizing mediastinitis secondary to retropharyngeal abscess in a child
• Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
• Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan
• 小児全身性エリテマトーデス(SLE)の治療におけるミゾリビン(MZR)の効果
• Long-term remission in three patients with childhood-onset systemic lupus erythematosus
• Latent cerebral hypoperfusion in a boy with persistent nephrotic syndrome
• Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus
• Acute disseminated encephalomyelitis and poststreptococcal acute glomerulonephritis
• Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy
• Acute pancreatitis associated with systemic lupus erythematosus: Successful treatment with plasmapheresis followed by aggressive immunosuppressive therapy.
• D-galactosamine/Lipopolysaccharide による肝障害モデルで cytochrome c はミトコンドリアから細胞質そして循環血液中へ移行する
• Contribution of CD4^+ or CD8^+ T cell subsets in the induction of asthma in C57BL/6 mice
• Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy
• The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis
• Hyper-IgD syndrome with novel mutation in a Japanese girl
• Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease
• Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis
• Plasma proteomics of Kawasaki disease by two-dimensional difference gel electrophoresis and mass spectrometry
• Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children
• 早産児における血中 soluble tumor necrosis factor receptor-1 の経時的変化と慢性肺疾患との関係
• Foreword
• 本邦における不明熱をきたす小児熱性疾患の全国実態調査
• NICUにおける早期退院と再入院率の検討
• Mizoribine : Mode of action and effects in clinical use
• Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
• Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis : experience from Japanese clinical trials
• Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan
• Guidance on using tocilizumab for juvenile idiopathic arthritis
• Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general
• De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis
• Association of HLA-A^*02:06 and HLA-DRB1^*04:05 with clinical subtypes of juvenile idiopathic arthritis
• Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan
• Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis : systemic arthritis and polyarthritis
• Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
• Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
• Clinical analysis of 50 children with juvenile dermatomyositis
• Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan

もっと見る 閉じる

スポンサーリンク